ArticleACS medicinal chemistry letters2021

Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease.

Katsushi Katayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.